GB Sciences, Inc.
GBLX · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $3 |
| Total Curr. Assets | $0 | $0 | $0 | $4 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | -$42,819 | -$2,222,072 | -$1,706,760 |
| Intangibles | $0 | $42,819 | $2,222,074 | $1,706,762 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $6 |
| Total NC Assets | $0 | $0 | $2 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $0 | $3 | $11 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $2 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $4 |
| Tax Payable | $1 | $1 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $2 |
| Other Curr. Liab. | $1 | $0 | $1 | $0 |
| Total Curr. Liab. | $5 | $5 | $4 | $9 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $3 |
| Total NC Liab. | $0 | $0 | $0 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5 | $5 | $4 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$110 | -$109 | -$105 | -$104 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $105 | $104 | $103 | $102 |
| Total Equity | -$5 | -$4 | -$2 | -$1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $0 | $0 | $3 | $11 |
| Net Debt | $2 | $1 | $1 | $4 |